Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 133

Results For "Officer"

1893 News Found

Agilent Laboratory achieves Green Lab certification
News | June 22, 2022

Agilent Laboratory achieves Green Lab certification

This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.


AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza
News | June 22, 2022

AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza

LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)


Cadila Pharma launches formulation development lab
News | June 21, 2022

Cadila Pharma launches formulation development lab

The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab


Parexel expands patient access to clinical trials through new community alliance network
Clinical Trials | June 21, 2022

Parexel expands patient access to clinical trials through new community alliance network

Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials


Unilever, Genomatica form venture to develop palm oil based alternatives
News | June 20, 2022

Unilever, Genomatica form venture to develop palm oil based alternatives

With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology


Dr. Reddy's Lab launches sorafenib tablets in US
News | June 15, 2022

Dr. Reddy's Lab launches sorafenib tablets in US

Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.


Piramal Pharma expands API capabilities at Digwal
News | June 15, 2022

Piramal Pharma expands API capabilities at Digwal

Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies


ProBioGen  and ValenzaBio enter second service agreement
Biotech | June 15, 2022

ProBioGen and ValenzaBio enter second service agreement

The new program includes upstream and downstream process development and large-scale GMP production.


InfuSystem and Ventis ink sales agreement for pain management
News | June 15, 2022

InfuSystem and Ventis ink sales agreement for pain management

The company will offer Ventis Pharma’s patented local anesthetic compound, Endura-KitTM for post-operative surgical and chronic pain management


FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer
Drug Approval | June 14, 2022

FDA accepts application for Merck’s Keytruda as adjuvant therapy for Stage IB-IIIA lung cancer

Acceptance based on results from the phase 3 KEYNOTE-091 trial